Assessment of Neuropathic Pain
N. Attal
Hôpital Ambroise Paré, APHP, Boulogne - Billancourt, France
Search for more papers by this authorR. Baron
Universitatsklinikum Schleswig-Holstein, Kiel, Germany
Search for more papers by this authorN. Attal
Hôpital Ambroise Paré, APHP, Boulogne - Billancourt, France
Search for more papers by this authorR. Baron
Universitatsklinikum Schleswig-Holstein, Kiel, Germany
Search for more papers by this authorNils Erik Gilhus MD, PhD
Professor
Department of Clinical Medicine, University of Bergen and Department of Neurology, Haukeland University Hospital, Bergen, Norway
Search for more papers by this authorMichael P. Barnes MD, FRCP
Professor of Neurological Rehabilitation Medical Director
University of Newcastle, Hunters Moor Neurorehabilitation Ltd, Newcastle upon Tyne, UK
Search for more papers by this authorMichael Brainin MD
Professor
Department of Clinical Medicine and Prevention, and Center for Clinical Neurosciences, Donau-Universität Krems, Department of Neurology, Landesklinikum Donauregion Tulln Tulln, Austria
Search for more papers by this authorNils Erik Gilhus MD, PhD
Professor
Department of Clinical Medicine, University of Bergen and Department of Neurology, Haukeland University Hospital, Bergen, Norway
Search for more papers by this authorMichael P. Barnes MD, FRCP
Professor of Neurological Rehabilitation Medical Director
University of Newcastle, Hunters Moor Neurorehabilitation Ltd, Newcastle upon Tyne, UK
Search for more papers by this authorMichael Brainin MD
Professor
Department of Clinical Medicine and Prevention, and Center for Clinical Neurosciences, Donau-Universität Krems, Department of Neurology, Landesklinikum Donauregion Tulln Tulln, Austria
Search for more papers by this authorSummary
This chapter contains sections titled:
-
Background and objectives
-
Search methods
-
Considerations on the methods of assessment in light of the new definition and grading system
-
Screening and assessment tools
-
Quantitative sensory testing
-
Neurophysiology
-
Functional neuroimaging
-
Skin biopsy
-
Conclusions
-
References
References
- Cruccu G, Anand P, Attal N, et al. EFNS guidelines on neuropathic pain assessment. Eur J Neurol 2004; 11: 153–62.
- Brainin M, Barnes M, Baron JC, et al. Guideline Standards Subcommittee of the EFNS Scientific Committee. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces–revised recommendations. Eur J Neurol 2004; 11: 577–81.
- Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008; 70: 1630–5.
- Merskey H, Bogduk N. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. Seattle: IASP Press, 1994.
- Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005; 114: 29–36.
- Scholz J, Mannion RJ, Hord DE, et al. A novel tool for the assessment of pain: validation in low back pain. Plos Med 2009; e1000047.
- Melzack R. The MacGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1: 275–99.
- Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain 2005; 6: 149–58.
- Bennett MI. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 2001; 92: 147–57.
- Krause SJ, Backonja M. Development of a neuropathic pain questionnaire. Clin J Pain 2003; 19: 306–14.
- Backonja MM, Krause SJ. Neuropathic Pain Questionnaire–short form. Clin J Pain 2003; 19: 315–6.
- Freynhagen R, Baron R, Gockel U, Tolle T. PainDetect: a new screeing questionnaire to detect neuropathic components in patients with back pain. Curr Med Res Opin 2006; 22: 1911–20.
- Portenoy R for the ID Pain Steering Committee. Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin 2006; 22: 1555–65.
- Cruccu G, Truini A. Tools for assessing neuropathic pain. Plos Med 2009;(6): e1000045.
- Melzack R. The short-form McGill Pain Questionnaire. Pain 1987; 30: 191–7.
- Dworkin RH, Turk DC, Revicki DA, et al. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain 2009; 144: 35–42.
- Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997; 48: 332–8.
- Jensen MP, Friedman M, Bonzo D, Richards P. The validity of the neuropathic pain scale for assessing diabetic neuropathic pain in a clinical trial. Clin J Pain 2006; 22: 97–103.
- Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the neuropathic pain symptom inventory. Pain 2004; 108: 248–57.
- Chien A, Eliav E, Sterling M. Whiplash (grade II) and cervical radiculopathy share a similar sensory presentation: an investigation using quantitative sensory testing. Clin J Pain 2008; 24: 595–603.
- Finnerup NB, Sørensen L, Biering-Sørensen F, Johannesen IL, Jensen TS. Segmental hypersensitivity and spinothalamic function in spinal cord injury pain. Exp Neurol 2007; 207: 139–49.
- Freynhagen R, Rolke R, Baron R, et al. Pseudoradicular and radicular low-back pain–a disease continuum rather than different entities? Answers from quantitative sensory testing. Pain 2008; 135: 65–74.
- Rader AJ. Surgical decompression in lower-extremity diabetic peripheral neuropathy. J Am Podiatr Med Assoc 2005; 95: 446–50.
- Geber C, Magerl W, Fondel R, et al. Numbness in clinical and experimental pain–a cross-sectional study exploring the mechanisms of reduced tactile function. Pain 2008; 139: 73–81.
- Rolke R, Baron R, Maier C, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 2006; 123: 231–43.
- Rolke R, Magerl W, Campbell KA, et al. Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain 2006; 10: 77–88.
- Devigili G, Tugnoli V, Penza P, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 2008; 131: 1912–25.
- Laaksonen SM, Röyttä M, Jääskeläinen SK, Kantola I, Penttinen M, Falck B. Neuropathic symptoms and findings in women with Fabry disease. Clin Neurophysiol 2008; 119: 1365–72.
- Attal N, Rouaud J, Brasseur L, Chauvin M, Bouhassira D. Systemic lidocaine in pain due to peripheral nerve injury and predictors of response. Neurology 2004; 62: 218–25.
- Edwards RR, Haythornthwaite JA, Tella P, Max MB, Raja S. Basal heat pain thresholds predict opioid analgesia in patients with postherpetic neuralgia. Anesthesiology 2006; 104: 1243–8.
- Finnerup NB, Biering-Sorensen F, Johannesen IL, et al. Intravenous lidocaine relieves spinal cord injury pain:a randomized controlled trial. Anesthesiology 2005; 102: 1023–30.
- Herrmann DN, McDermott MP, Sowden JE, et al. Is skin biopsy a predictor of transition to symptomatic HIV neuropathy? A longitudinal study. Neurology 2006; 66: 857–61.
- Krämer HH, Rolke R, Bickel A, Birklein F. Thermal thresholds predict painfulness of diabetic neuropathies. Diabetes Care 2004; 27: 2386–91.
- Stiasny-Kolster K, Magerl W, Oertel WH, Möller JC, Treede RD. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain 2004; 127: 773–82.
- Wasner G, Kleinert A, Binder A, Schattschneider J, Baron R. Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin. J Neurol 2005; 252: 677–86.
- Yucel A, Ozyalcin S, Koknel Talu G, et al. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study. Eur J Pain 2005; 9: 407–16.
- Ochoa J, Torebjörk E. Sensations evoked by intraneural microstimulation of C nociceptor fibres in human skin nerves. J Physiol 1989; 415: 583–99.
- Eckberg DL, Wallin BK, Fagius J, Lundberg L, Torebjörk HE. Prospective study of symptoms after human microneurography. Acta Physiol Scand 1989; 137: 567–9.
- Littell H. After-effect of microneurography in humans. Part IV. Phys Ther 1981; 61: 1585–6.
- Jørum E, Schmelz M. Chapter 29 Microneurography in the assessment of neuropathic pain. Handb Clin Neurol 2006; 81: 427–38.
- Bostock H, Campero M, Serra J, Ochoa JL. Temperature-dependent double spikes in C-nociceptors of neuropathic pain patients. Brain 2005; 128: 2154–63.
- Ochoa J, Campero M, Serra J, Bostock H. Hyperexcitable polymodal and insensitive nociceptors in painful human neuropathy. Muscle Nerve 2005; 32: 459–72.
- Orstavik K, Jørum E. Microneurographic findings of relevance to pain in patients with erythromelalgia and patients with diabetic neuropathy. Neurosci Lett 2010; 470: 180–84.
- Serra J, Campero M, Bostock H, Ochoa J. Two types of C nociceptors in human skin and their behavior in areas of capsaicin-induced secondary hyperalgesia. J Neurophysiol 2004; 91: 2770–81.
- Cruccu G, Biasiotta A, Di Rezze S, et al. Trigeminal neuralgia and pain related to multiple sclerosis. Pain 2009; 143: 186–91.
- Cruccu G, Biasiotta A, Galeotti F, Iannetti GD, Truini A, Gronseth G. Diagnostic accuracy of trigeminal reflex testing in trigeminal neuralgia. Neurology 2006; 66: 139–41.
- Cruccu G, Gronseth G, Alksne J, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 2008; 15: 1013–28.
- Gronseth G, Cruccu G, Alksne J, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 2008; 71: 1183–90.
- Truini A, Galeotti F, Haanpaa M, et al. Pathophysiology of pain in postherpetic neuralgia: a clinical and neurophysiological study. Pain 2008; 140: 405–10.
- Baad-Hansen L, List T, Kaube H, Jensen TS, Svensson P. Blink reflexes in patients with atypical odontalgia and matched healthy controls. Exp Brain Res 2006; 172: 498–506.
- Truini A, Galeotti F, Biasiotta A, et al. Dissociation between cutaneous silent period and laser evoked potentials in assessing neuropathic pain. Muscle Nerve 2009; 39: 369–73.
- Truini A, Padua L, Biasiotta A, et al. Differential involvement of A-delta and A-beta fibres in neuropathic pain related to carpal tunnel syndrome. Pain 2009; 145: 105–9.
- Cruccu G, Aminoff MJ, Curio G, et al. Recommendations for the clinical use of somatosensory-evoked potentials. Clin Neurophysiol 2008; 119: 1705–19.
- Granovsky Y, Matre D, Sokolik A, Lorenz J, Casey KL. Thermoreceptive innervation of human glabrous and hairy skin: a contact heat evoked potential analysis. Pain 2005; 115: 238–47.
- Katsarava Z, Ayzenberg I, Sack F, Limmroth V, Diener HC, Kaube H. A novel method of eliciting pain-related potentials by transcutaneous electrical stimulation. Headache 2006; 46: 1511–7.
- Lefaucheur JP, Créange A. Neurophysiological testing correlates with clinical examination according to fibre type involvement and severity in sensory neuropathy. J Neurol Neurosurg Psychiatry 2004; 75: 417–22.
- Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 2005; 9: 463–84.
- Peyron R, Laurent B, Garcia-Larrea L. Functional imaging of pain. A review and meta-analysis. Neurophysiol Clin 2000; 30: 263–88.
- Garcia-Larrea L, Maarrawi J, Peyron R, et al. On the relation between sensory deafferentation, pain and thalamic activity in Wallenberg's syndrome: a PET-scan study before and after motor cortex stimulation. Eur J Pain 2006; 10: 677–88.
- Garcia-Larrea L, Peyron R, Mertens P, et al. Electrical stimulation of motor cortex for pain control: a combined PET-scan and electrophysiological study. Pain 1999; 83: 259–73.
- Hsieh JC, Belfrage M, Stone-Elander S, Hansson P, Ingvar M. Central representation of chronic ongoing neuropathic pain studied by positron emission tomography. Pain 1995; 63: 225–36.
- Iadarola MJ, Max MB, Berman KF, et al. Unilateral decrease in thalamic activity observed with positron emission tomography in patients with chronic neuropathic pain. Pain 1995; 63: 55–64.
-
Baron R, Baron Y, Disbrow E, Roberts TP. Brain processing of capsaicin-induced secondary hyperalgesia: a functional MRI study. Neurology 1999; 11: 548–57.
10.1212/WNL.53.3.548 Google Scholar
- Peyron R, Schneider F, Faillenot I, et al. An fMRI study of cortical representation of mechanical allodynia in patients with neuropathic pain. Neurology 2004; 63: 1838–46.
- Schweinhardt P, Glynn C, Brooks J, et al. An fMRI study of cerebral processing of brushevoked allodynia in neuropathic pain patients. Neuroimage 2006; 32: 256–65.
- Ducreux D, Attal N, Parker F, Bouhassira D. Mechanisms of central neuropathic pain: a combined psychophysical and fMRI study in syringomyelia. Brain 2006; 129: 963–76.
- Witting N, Kupers RC, Svensson P, Jensen TS. A PET activation study of brush-evoked allodynia in patients with nerve injury pain. Pain 2006; 120: 145–54.
- Maihöfner C, Handwerker HO, Birklein F. Functional imaging of allodynia in complex regional pain syndrome. Neurology 2006; 66: 711–7.
- Jones AK, Watabe H, Cunningham VJ, Jones T. Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11 C] diprenorphine binding and PET. Eur J Pain 2004; 8: 479–85.
- Maarrawi J, Peyron R, Mertens P, et al. Differential brain opioid receptor availability in central and peripheral neuropathic pain. Pain 2007; 127: 183–94.
- Willoch F, Schindler F, Wester HJ, et al. Central poststroke pain and reduced opioid receptor binding within pain processing circuitries: a [11C]diprenorphine PET study. Pain 2004; 108: 213–20.
- Lauria G, Cornblath DR, Johansson O, et al. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol 2005; 12: 747–58.
- Sommer C, Lauria G. Skin biopsy in the management of peripheral neuropathy. Lancet Neurol 2007; 6: 632–42.
- Gorson KC, Herrmann DN, Thiagarajan R, et al. Non-length dependent small fibre neuropathy/ganglionopathy. J Neurol Neurosurg Psychiatry 2008; 79: 163–9.
- Scherens A, Maier C, Haussleiter IS, et al. Psychophysical and neuropathological findings in patients with dysaesthesias at the lower limb. Eur J Pain 2009; 13: 711–8.
- Vlckova-Moravcova E, Bednarik J, Dusek L, et al. Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies. Muscle Nerve 2008; 37: 50–60.
- Atherton DD, Facer P, Roberts KM, et al. Use of the novel contact heat evoked potential stimulator (CHEPS) for the assessment of small fibre neuropathy: correlations with skin flare responses and intra-epidermal nerve fibre counts. BMC Neurol 2007; 7: 21.
- Loseth S, Stalberg E, Jorde R, Mellgren SI. Early diabetic neuropathy: thermal thresholds and intraepidermal nerve fibre density in patients with normal nerve conduction studies. J Neurol 2008; 255: 1197–202.
- Sorensen L, Molyneaux L, Yue DK. The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care 2006; 29: 883–7.
- Oaklander AL. The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles. Pain 2001; 92: 139–45.
- Petersen KL, Fields HL, Brennum J, et al. Capsaicin evoked pain and allodynia in post-herpetic neuralgia. Pain 2000; 88: 125–33.
- Rowbotham MC, Yosipovitch G, Connolly MK, et al. Cuta- neous innervation density in the allodynic form of postherpetic neuralgia. Neurobiol Dis 1996; 3: 205–14.
- Albrecht PJ, Hines S, Eisenberg E, et al. Pathologic alterations of cutaneous innervation and vasculature in affected limbs from patients with complex regional pain syndrome. Pain 2006; 120: 244–66.
- Oaklander AL, Rissmiller JG, Gelman LB, et al. Evidence of focal small-fiber axonal degeneration in complex regional pain syndrome-I (reflex sympathetic dystrophy). Pain 2006; 120: 235–43.